Moreover, a randomized, double-blind, placebo-controlled clinical trial reported that Chlorella vulgaris can decrease serum glucose level and improve liver function and lipid profile in NAFLD patients [200]; further, in the same line, Javadi (2017) showed that prebiotic inulin reduces AST and ALT levels, compared to placebo. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.